These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1421033

  • 21. Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer.
    Cooper EH, Whelan P, Purves D.
    Prostate; 1994 Nov; 25(5):236-42. PubMed ID: 7526352
    [Abstract] [Full Text] [Related]

  • 22. Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases.
    Berruti A, Dogliotti L, Gorzegno G, Torta M, Tampellini M, Tucci M, Cerutti S, Frezet MM, Stivanello M, Sacchetto G, Angeli A.
    Clin Chem; 1999 Aug; 45(8 Pt 1):1240-7. PubMed ID: 10430790
    [Abstract] [Full Text] [Related]

  • 23. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity.
    Mayne PD, Thakrar S, Rosalki SB, Foo AY, Parbhoo S.
    J Clin Pathol; 1987 Apr; 40(4):398-403. PubMed ID: 3584482
    [Abstract] [Full Text] [Related]

  • 24. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
    Zulauf N, Brüggmann D, Groneberg D, Oremek GM.
    Oncology; 2019 Apr; 97(4):236-244. PubMed ID: 31412345
    [Abstract] [Full Text] [Related]

  • 25. Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
    Nishimukai A, Higuchi T, Ozawa H, Yanai A, Miyagawa Y, Murase K, Imamura M, Takatsuka Y, Miyoshi Y.
    Breast Cancer; 2017 Mar; 24(2):245-253. PubMed ID: 27040403
    [Abstract] [Full Text] [Related]

  • 26. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
    Takahashi M, Kushida K, Hoshino H, Miura M, Ohishi T, Inoue T.
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):177-83. PubMed ID: 9302392
    [Abstract] [Full Text] [Related]

  • 27. Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?
    Bombardieri E, Martinetti A, Miceli R, Mariani L, Castellani MR, Seregni E.
    Eur J Nucl Med; 1997 Nov; 24(11):1349-55. PubMed ID: 9371866
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross-links for detection of bone metastases.
    Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H.
    Clin Biochem; 1995 Oct; 28(5):511-9. PubMed ID: 8582050
    [Abstract] [Full Text] [Related]

  • 29. Biochemical markers and skeletal metastases.
    Demers LM, Costa L, Lipton A.
    Cancer; 2000 Jun 15; 88(12 Suppl):2919-26. PubMed ID: 10898335
    [Abstract] [Full Text] [Related]

  • 30. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M, Bonneterre J, Hecquet B, Desoize B, Demaille A.
    Anticancer Res; 1991 Jun 15; 11(2):831-3. PubMed ID: 2064338
    [Abstract] [Full Text] [Related]

  • 31. Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results.
    Lumachi F, Marino F, Fanti G, Chiara GB, Basso SM.
    Anticancer Res; 2011 Nov 15; 31(11):3879-81. PubMed ID: 22110213
    [Abstract] [Full Text] [Related]

  • 32. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J, Lorente JA, Encabo G.
    Cancer; 1996 Dec 01; 78(11):2374-8. PubMed ID: 8941009
    [Abstract] [Full Text] [Related]

  • 33. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA, Valenzuela H, Morote J, Gelabert A.
    Eur J Nucl Med; 1999 Jun 01; 26(6):625-32. PubMed ID: 10369948
    [Abstract] [Full Text] [Related]

  • 34. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ, Wolfert RL, Hill CS.
    Horm Metab Res; 1991 Nov 01; 23(11):559-61. PubMed ID: 1816067
    [Abstract] [Full Text] [Related]

  • 35. Sequential estimation of alkaline phosphatase isoenzymes (API) in breast cancer patients.
    Horner GU, Caffier HO.
    Cancer Detect Prev; 1981 Nov 01; 4(1-4):205-9. PubMed ID: 7349778
    [Abstract] [Full Text] [Related]

  • 36. Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
    Ritzke C, Stieber P, Untch M, Nagel D, Eiermann W, Fateh-Moghadam A.
    Anticancer Res; 1998 Nov 01; 18(2B):1243-9. PubMed ID: 9615795
    [Abstract] [Full Text] [Related]

  • 37. Bone alkaline phosphatase in rheumatic diseases.
    Beyeler C, Banks RE, Thompson D, Forbes MA, Cooper EH, Bird H.
    Ann Clin Biochem; 1995 Jul 01; 32 ( Pt 4)():379-84. PubMed ID: 7486797
    [Abstract] [Full Text] [Related]

  • 38. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
    Korpela J, Tiitinen SL, Hiekkanen H, Halleen JM, Selander KS, Väänänen HK, Suominen P, Helenius H, Salminen E.
    Anticancer Res; 2006 Jul 01; 26(4B):3127-32. PubMed ID: 16886645
    [Abstract] [Full Text] [Related]

  • 39. [Measurement of skeletal alkaline phosphatase in prostatic carcinoma. Preliminary report].
    Casetta G, Gamba P, Piana P, Pecchio F, Tizzani A.
    Minerva Urol Nefrol; 1995 Mar 01; 47(1):9-12. PubMed ID: 7570264
    [Abstract] [Full Text] [Related]

  • 40. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
    Woitge HW, Seibel MJ, Ziegler R.
    Clin Chem; 1996 Nov 01; 42(11):1796-804. PubMed ID: 8906079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.